Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7.25M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
4.2M
-
Shares change
-
+2.64M
-
Total reported value, excl. options
-
$28.2M
-
Value change
-
+$18.3M
-
Put/Call ratio
-
0.06
-
Number of buys
-
39
-
Number of sells
-
-3
-
Price
-
$6.72
Significant Holders of Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) as of Q4 2024
47 filings reported holding KZR - Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Kezar Life Sciences, Inc. - Common Stock, par value $0.001 per share (KZR) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.2M shares
of 7.25M outstanding shares and own 57.9% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (720K shares), SUVRETTA CAPITAL MANAGEMENT, LLC (717K shares), Avidity Partners Management LP (503K shares), VANGUARD GROUP INC (274K shares), ORBIMED ADVISORS LLC (193K shares), ADAR1 Capital Management, LLC (147K shares), ACADIAN ASSET MANAGEMENT LLC (146K shares), Affinity Asset Advisors, LLC (142K shares), Peapod Lane Capital LLC (124K shares), and Stonepine Capital Management, LLC (110K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.